Benzinga · Oct 28, 2026
Freedom Broker Maintains Hold on Acme United, Raises Price Target to $70
Freedom Broker analyst Georgy Vashchenko maintains Acme United (AMEX:ACU) with a Hold and raises the price target from $58 to $70.
AMEX · ACU
Consumer Defensive · Household & Personal Products
$69.50
Up+$2.30 (+3.31%)
Updated Nov 4, 2026, 6:08 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ACU
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
ACU closed at $69.50 after 21 trading sessions, up 10.09% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $67.00 | $70.00 | $67.00 | $69.50 | 45.74K |
| Nov 2, 2026 | $68.48 | $69.68 | $66.32 | $68.99 | 53.08K |
| Oct 30, 2026 | $69.00 | $69.63 | $67.26 | $67.26 | 33.75K |
| Oct 29, 2026 | $68.00 | $69.83 | $67.33 | $68.11 | 37.92K |
| Oct 28, 2026 | $64.84 | $67.04 | $64.00 | $66.85 | 34.02K |
| Oct 27, 2026 | $65.18 | $67.3199 | $64.00 | $65.78 | 77.46K |
| Oct 26, 2026 | $64.12 | $64.8381 | $63.32 | $63.58 | 22.3K |
| Oct 23, 2026 | $63.62 | $63.795 | $63.15 | $63.48 | 19.45K |
| Oct 22, 2026 | $63.06 | $64.46 | $62.87 | $64.17 | 20.46K |
| Oct 21, 2026 | $63.63 | $63.63 | $62.74 | $63.20 | 47.14K |
| Oct 20, 2026 | $61.52 | $64.56 | $61.52 | $63.58 | 67.41K |
| Oct 19, 2026 | $61.42 | $62.19 | $60.98 | $61.17 | 25.45K |
| Oct 16, 2026 | $62.30 | $62.58 | $60.8016 | $61.52 | 21.73K |
| Oct 15, 2026 | $61.65 | $62.3125 | $60.2901 | $61.96 | 32.99K |
| Oct 14, 2026 | $62.11 | $62.48 | $60.84 | $61.38 | 39.73K |
| Oct 13, 2026 | $61.925 | $62.46 | $61.2901 | $62.37 | 17.82K |
| Oct 12, 2026 | $62.06 | $62.50 | $61.5043 | $62.50 | 19.89K |
| Oct 9, 2026 | $61.91 | $62.91 | $61.81 | $62.15 | 23.61K |
| Oct 8, 2026 | $62.29 | $62.91 | $61.35 | $61.94 | 51.17K |
| Oct 7, 2026 | $62.94 | $63.39 | $61.62 | $61.98 | 28.68K |
| Oct 6, 2026 | $63.77 | $63.95 | $62.75 | $63.13 | 21.02K |
The latest Smart Investors Daily articles mentioning ACU.
Company
Market Activity
Research & News
ACU research
Company profile and research snapshot.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 28, 2026 | Freedom Broker | Hold | — |
No generated briefing is available yet.
Benzinga · Oct 28, 2026
Freedom Broker analyst Georgy Vashchenko maintains Acme United (AMEX:ACU) with a Hold and raises the price target from $58 to $70.
Yahoo · Oct 28, 2026
Acme United stock barely moved after its Q3 2026 release, ticking down just 0.03% in afternoon trading. Yet the headline story is much louder than the price. The company posted Q3 sales of US$58.0m and basic earnings per share of US$0.88, with a powerful lift from a one time US$6.0m tariff refund that flattered margins. Traders focusing on the muted chart risk missing the real issue, which is how much of this profitability is repeatable once that refund and plant closure items roll off in the...
SeekingAlpha · Oct 28, 2026
Acme United delivered strong Q3 results, with revenue up 18.2% and EPS beating estimates by $0.14. Learn why ACU stock is a hold.
Yahoo · Oct 28, 2026
Automation and RFID-enabled refill systems are reshaping how Acme generates profit, not just revenue.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning ACU.